Antiparasitic chaiyaphumines from entomopathogenic <em>Xenorhabdus</em> sp. PB61.4 (Publications)
(1) showed good activity against Plasmodium falciparum (IC50 of 0.61 muM), the causative agent of malaria, and was active against other protozoal tropical disease causing agents
Causes of fever in returning travelers: a European multicenter prospective cohort study (Publications)
diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting
Discovery and optimisation studies of antimalarial phenotypic hits (Publications)
a mammalian cell line (L6). One example showed no significant activity against a rodent model of malaria, and more work is needed to optimise these compounds
Antiparasitic chaiyaphumines from entomopathogenic <em>Xenorhabdus</em> sp. PB61.4 (Publications)
(1) showed good activity against Plasmodium falciparum (IC50 of 0.61 muM), the causative agent of malaria, and was active against other protozoal tropical disease causing agents
Antiplasmodial activity of a series of 1,3,5-triazine-substituted polyamines (Publications)
some parasitic protozoa and it is proposed that the pathway might also represent a target in the malaria parasite Plasmodium falciparum. A series of 1,3,5-triazine-substituted polyamine analogues were tested
Discovery and optimisation studies of antimalarial phenotypic hits (Publications)
a mammalian cell line (L6). One example showed no significant activity against a rodent model of malaria, and more work is needed to optimise these compounds
Antiplasmodial activity of a series of 1,3,5-triazine-substituted polyamines (Publications)
some parasitic protozoa and it is proposed that the pathway might also represent a target in the malaria parasite Plasmodium falciparum. A series of 1,3,5-triazine-substituted polyamine analogues were tested
Causes of fever in returning travelers: a European multicenter prospective cohort study (Publications)
diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting
Global health at a crossroads: Who will fill the gap? (Page)
https://www.swisstph.ch/en/impact-stories/global-health-at-a-crossroads-who-will-fill-the-gap/blog-id/102
communities: Malaria research and control in Tanzania : Our long-standing partner, the Ifakara Health Institute (IHI), will lose a USD 17.9 million USAID grant, endangering progress towards malaria elimination [...] health programmes are being scaled back or shut down. Millions of people who rely on HIV treatment, malaria prevention or neglected tropical disease (NTD) control are being left behind. Photo credit: Riccardo [...] single donor can fill. Major funding institutions are scaling back :...
Health Systems and Interventions | Swiss TPH (Page)
https://www.swisstph.ch/en/topics/health-systems-and-interventions
projects or monitor the allocation of funds provided by the Global Fund to Fight AIDS, Tuberculosis and Malaria in many countries in Africa and Asia.
